« Back
Home /
SB 202190

SB 202190

Item no.	M2062-100mg
Manufacturer	AbMole
CASRN	152121-30-7
Amount	100mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	0,9967
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	SB202190
Similar products	SB 202190
Available
Target Information	p38 MAPK
Molecular Weight	331, 34
Solubility	DMSO 36 mg/mL
Bioactivity information	SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2062-100mg-safety-datasheet.pdf